PTGS2 and neoplasm: Silencing of TGFβ and Cox2 at this siRNA concentration reduced tumor, but at 43 and 50 days we see that inclusion of anti-PDL1 mAbs further reduces tumor viability compared to siRNAs alone (Figure 3C).